David Eglin received the Jean Leray Award
The contribution of the AO Research Institute Davos to the field of biomaterials has again been recognized by The European Society for Biomaterials.
27 May 2011
The contribution of the AO Research Institute Davos (ARI) to the field of biomaterials has again been recognized by The European Society for Biomaterials. Eight years after Prof Geoff Richards received the Jean Leray Award, the society has nominated David Eglin as the recipient of this year's Jean Leray Award.
This prestigious award is established to recognize, encourage and stimulate outstanding research contributions to the field of biomaterials and is given to a researcher under 40 who has demonstrated distinctive achievement and insight in biomaterials research.
David Eglin is a principal scientist and leader of the Polymers and Surfaces team in the Musculoskeletal Regeneration program (Prof Mauro Alini) at the AO Research Institute Davos in Switzerland. Eglin's research interests lie in macromolecular chemistry and material science, focusing on polymers for medical devices, tissue engineering and regenerative medicine. He develops scaffolds, membranes and hydrogels for both the understanding of cell-material interactions and for translational research in the orthopedic field.
Eglin has recently been awarded, as a co-applicant, a European grant to develop gene activated matrices for bone and cartilage regeneration in arthritis and an AO-CMF grant on multifunctional scaffolds for polytraumatic large bone defects.
David Eglin has been a member of both the European and the Swiss Societies for Biomaterials since 2006. He has published over 30 articles, as well as book chapters and several patents, and delivered more than 50 national and international invited lectures. He is a member of the international editorial review board of the eCM Journal and a reviewer for many journals in the biomaterials field.
The award ceremony will take place in September 2011, in Dublin (Ireland), during the 24th European Conference on Biomaterials.
We are proud of his achievement and wish him further success in the future with translation of these ideas and projects into devices which will improve patient care.